Gene Therapy-Global Market Status and Trend Report 2016-2026
Report Summary
Gene Therapy-Global Market Status and Trend Report 2016-2026 offers a comprehensive analysis on Gene Therapy industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Regional Market Size of Gene Therapy 2016-2021, and development forecast 2022-2026
Main manufacturers/suppliers of Gene Therapy worldwide, with company and product introduction, position in the Gene Therapy market
Market status and development trend of Gene Therapy by types and applications
Cost and profit status of Gene Therapy, and marketing status
Market growth drivers and challengesSince the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency.The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Ammonium Gene Therapy market in 2020.COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.This report also analyses the impact of Coronavirus COVID-19 on the Gene Therapy industry.
The report segments the global Gene Therapy market as:
Global Gene Therapy Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2016-2026):
North America
Europe
China
Japan
Rest APAC
Latin America
Global Gene Therapy Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2016-2026):
Viral Gene Therapy
Non-Viral Gene Therapy
Global Gene Therapy Market: Application Segment Analysis (Consumption Volume and Market Share 2016-2026; Downstream Customers and Market Analysis)
Neurological Diseases
Cancer
Other
Global Gene Therapy Market: Manufacturers Segment Analysis (Company and Product introduction, Gene Therapy Sales Volume, Revenue, Price and Gross Margin):
Biogen
Novartis
Gilead Sciences
Sarepta Therapeutics
Alnylam Pharmaceuticals
Amgen
Spark Therapeutics
Akcea Therapeutics
bluebird bio
Sunway Biotech
SIBIONO
AnGes
Orchard Therapeutics
Human Stem Cells Institute
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Gene Therapy-Global Market Status and Trend Report 2016-2026 offers a comprehensive analysis on Gene Therapy industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Regional Market Size of Gene Therapy 2016-2021, and development forecast 2022-2026
Main manufacturers/suppliers of Gene Therapy worldwide, with company and product introduction, position in the Gene Therapy market
Market status and development trend of Gene Therapy by types and applications
Cost and profit status of Gene Therapy, and marketing status
Market growth drivers and challengesSince the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency.The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Ammonium Gene Therapy market in 2020.COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.This report also analyses the impact of Coronavirus COVID-19 on the Gene Therapy industry.
The report segments the global Gene Therapy market as:
Global Gene Therapy Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2016-2026):
North America
Europe
China
Japan
Rest APAC
Latin America
Global Gene Therapy Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2016-2026):
Viral Gene Therapy
Non-Viral Gene Therapy
Global Gene Therapy Market: Application Segment Analysis (Consumption Volume and Market Share 2016-2026; Downstream Customers and Market Analysis)
Neurological Diseases
Cancer
Other
Global Gene Therapy Market: Manufacturers Segment Analysis (Company and Product introduction, Gene Therapy Sales Volume, Revenue, Price and Gross Margin):
Biogen
Novartis
Gilead Sciences
Sarepta Therapeutics
Alnylam Pharmaceuticals
Amgen
Spark Therapeutics
Akcea Therapeutics
bluebird bio
Sunway Biotech
SIBIONO
AnGes
Orchard Therapeutics
Human Stem Cells Institute
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF GENE THERAPY
1.1 Definition of Gene Therapy in This Report
1.2 Commercial Types of Gene Therapy
1.2.1 Viral Gene Therapy
1.2.2 Non-Viral Gene Therapy
1.3 Downstream Application of Gene Therapy
1.3.1 Neurological Diseases
1.3.2 Cancer
1.3.3 Other
1.4 Development History of Gene Therapy
1.5 Market Status and Trend of Gene Therapy 2016-2026
1.5.1 Global Gene Therapy Market Status and Trend 2016-2026
1.5.2 Regional Gene Therapy Market Status and Trend 2016-2026
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Gene Therapy 2016-2021
2.2 Production Market of Gene Therapy by Regions
2.2.1 Production Volume of Gene Therapy by Regions
2.2.2 Production Value of Gene Therapy by Regions
2.3 Demand Market of Gene Therapy by Regions
2.4 Production and Demand Status of Gene Therapy by Regions
2.4.1 Production and Demand Status of Gene Therapy by Regions 2016-2021
2.4.2 Import and Export Status of Gene Therapy by Regions 2016-2021
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Production Volume of Gene Therapy by Types
3.2 Production Value of Gene Therapy by Types
3.3 Market Forecast of Gene Therapy by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Gene Therapy by Downstream Industry
4.2 Market Forecast of Gene Therapy by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF GENE THERAPY
5.1 Global Economy Situation and Trend Overview
5.2 Gene Therapy Downstream Industry Situation and Trend Overview
CHAPTER 6 GENE THERAPY MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
6.1 Production Volume of Gene Therapy by Major Manufacturers
6.2 Production Value of Gene Therapy by Major Manufacturers
6.3 Basic Information of Gene Therapy by Major Manufacturers
6.3.1 Headquarters Location and Established Time of Gene Therapy Major Manufacturer
6.3.2 Employees and Revenue Level of Gene Therapy Major Manufacturer
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 GENE THERAPY MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Biogen
7.1.1 Company profile
7.1.2 Representative Gene Therapy Product
7.1.3 Gene Therapy Sales, Revenue, Price and Gross Margin of Biogen
7.2 Novartis
7.2.1 Company profile
7.2.2 Representative Gene Therapy Product
7.2.3 Gene Therapy Sales, Revenue, Price and Gross Margin of Novartis
7.3 Gilead Sciences
7.3.1 Company profile
7.3.2 Representative Gene Therapy Product
7.3.3 Gene Therapy Sales, Revenue, Price and Gross Margin of Gilead Sciences
7.4 Sarepta Therapeutics
7.4.1 Company profile
7.4.2 Representative Gene Therapy Product
7.4.3 Gene Therapy Sales, Revenue, Price and Gross Margin of Sarepta Therapeutics
7.5 Alnylam Pharmaceuticals
7.5.1 Company profile
7.5.2 Representative Gene Therapy Product
7.5.3 Gene Therapy Sales, Revenue, Price and Gross Margin of Alnylam Pharmaceuticals
7.6 Amgen
7.6.1 Company profile
7.6.2 Representative Gene Therapy Product
7.6.3 Gene Therapy Sales, Revenue, Price and Gross Margin of Amgen
7.7 Spark Therapeutics
7.7.1 Company profile
7.7.2 Representative Gene Therapy Product
7.7.3 Gene Therapy Sales, Revenue, Price and Gross Margin of Spark Therapeutics
7.8 Akcea Therapeutics
7.8.1 Company profile
7.8.2 Representative Gene Therapy Product
7.8.3 Gene Therapy Sales, Revenue, Price and Gross Margin of Akcea Therapeutics
7.9 bluebird bio
7.9.1 Company profile
7.9.2 Representative Gene Therapy Product
7.9.3 Gene Therapy Sales, Revenue, Price and Gross Margin of bluebird bio
7.10 Sunway Biotech
7.10.1 Company profile
7.10.2 Representative Gene Therapy Product
7.10.3 Gene Therapy Sales, Revenue, Price and Gross Margin of Sunway Biotech
7.11 SIBIONO
7.11.1 Company profile
7.11.2 Representative Gene Therapy Product
7.11.3 Gene Therapy Sales, Revenue, Price and Gross Margin of SIBIONO
7.12 AnGes
7.12.1 Company profile
7.12.2 Representative Gene Therapy Product
7.12.3 Gene Therapy Sales, Revenue, Price and Gross Margin of AnGes
7.13 Orchard Therapeutics
7.13.1 Company profile
7.13.2 Representative Gene Therapy Product
7.13.3 Gene Therapy Sales, Revenue, Price and Gross Margin of Orchard Therapeutics
7.14 Human Stem Cells Institute
7.14.1 Company profile
7.14.2 Representative Gene Therapy Product
7.14.3 Gene Therapy Sales, Revenue, Price and Gross Margin of Human Stem Cells Institute
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF GENE THERAPY
8.1 Industry Chain of Gene Therapy
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF GENE THERAPY
9.1 Cost Structure Analysis of Gene Therapy
9.2 Raw Materials Cost Analysis of Gene Therapy
9.3 Labor Cost Analysis of Gene Therapy
9.4 Manufacturing Expenses Analysis of Gene Therapy
CHAPTER 10 MARKETING STATUS ANALYSIS OF GENE THERAPY
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
1.1 Definition of Gene Therapy in This Report
1.2 Commercial Types of Gene Therapy
1.2.1 Viral Gene Therapy
1.2.2 Non-Viral Gene Therapy
1.3 Downstream Application of Gene Therapy
1.3.1 Neurological Diseases
1.3.2 Cancer
1.3.3 Other
1.4 Development History of Gene Therapy
1.5 Market Status and Trend of Gene Therapy 2016-2026
1.5.1 Global Gene Therapy Market Status and Trend 2016-2026
1.5.2 Regional Gene Therapy Market Status and Trend 2016-2026
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Gene Therapy 2016-2021
2.2 Production Market of Gene Therapy by Regions
2.2.1 Production Volume of Gene Therapy by Regions
2.2.2 Production Value of Gene Therapy by Regions
2.3 Demand Market of Gene Therapy by Regions
2.4 Production and Demand Status of Gene Therapy by Regions
2.4.1 Production and Demand Status of Gene Therapy by Regions 2016-2021
2.4.2 Import and Export Status of Gene Therapy by Regions 2016-2021
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Production Volume of Gene Therapy by Types
3.2 Production Value of Gene Therapy by Types
3.3 Market Forecast of Gene Therapy by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Gene Therapy by Downstream Industry
4.2 Market Forecast of Gene Therapy by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF GENE THERAPY
5.1 Global Economy Situation and Trend Overview
5.2 Gene Therapy Downstream Industry Situation and Trend Overview
CHAPTER 6 GENE THERAPY MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
6.1 Production Volume of Gene Therapy by Major Manufacturers
6.2 Production Value of Gene Therapy by Major Manufacturers
6.3 Basic Information of Gene Therapy by Major Manufacturers
6.3.1 Headquarters Location and Established Time of Gene Therapy Major Manufacturer
6.3.2 Employees and Revenue Level of Gene Therapy Major Manufacturer
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 GENE THERAPY MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Biogen
7.1.1 Company profile
7.1.2 Representative Gene Therapy Product
7.1.3 Gene Therapy Sales, Revenue, Price and Gross Margin of Biogen
7.2 Novartis
7.2.1 Company profile
7.2.2 Representative Gene Therapy Product
7.2.3 Gene Therapy Sales, Revenue, Price and Gross Margin of Novartis
7.3 Gilead Sciences
7.3.1 Company profile
7.3.2 Representative Gene Therapy Product
7.3.3 Gene Therapy Sales, Revenue, Price and Gross Margin of Gilead Sciences
7.4 Sarepta Therapeutics
7.4.1 Company profile
7.4.2 Representative Gene Therapy Product
7.4.3 Gene Therapy Sales, Revenue, Price and Gross Margin of Sarepta Therapeutics
7.5 Alnylam Pharmaceuticals
7.5.1 Company profile
7.5.2 Representative Gene Therapy Product
7.5.3 Gene Therapy Sales, Revenue, Price and Gross Margin of Alnylam Pharmaceuticals
7.6 Amgen
7.6.1 Company profile
7.6.2 Representative Gene Therapy Product
7.6.3 Gene Therapy Sales, Revenue, Price and Gross Margin of Amgen
7.7 Spark Therapeutics
7.7.1 Company profile
7.7.2 Representative Gene Therapy Product
7.7.3 Gene Therapy Sales, Revenue, Price and Gross Margin of Spark Therapeutics
7.8 Akcea Therapeutics
7.8.1 Company profile
7.8.2 Representative Gene Therapy Product
7.8.3 Gene Therapy Sales, Revenue, Price and Gross Margin of Akcea Therapeutics
7.9 bluebird bio
7.9.1 Company profile
7.9.2 Representative Gene Therapy Product
7.9.3 Gene Therapy Sales, Revenue, Price and Gross Margin of bluebird bio
7.10 Sunway Biotech
7.10.1 Company profile
7.10.2 Representative Gene Therapy Product
7.10.3 Gene Therapy Sales, Revenue, Price and Gross Margin of Sunway Biotech
7.11 SIBIONO
7.11.1 Company profile
7.11.2 Representative Gene Therapy Product
7.11.3 Gene Therapy Sales, Revenue, Price and Gross Margin of SIBIONO
7.12 AnGes
7.12.1 Company profile
7.12.2 Representative Gene Therapy Product
7.12.3 Gene Therapy Sales, Revenue, Price and Gross Margin of AnGes
7.13 Orchard Therapeutics
7.13.1 Company profile
7.13.2 Representative Gene Therapy Product
7.13.3 Gene Therapy Sales, Revenue, Price and Gross Margin of Orchard Therapeutics
7.14 Human Stem Cells Institute
7.14.1 Company profile
7.14.2 Representative Gene Therapy Product
7.14.3 Gene Therapy Sales, Revenue, Price and Gross Margin of Human Stem Cells Institute
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF GENE THERAPY
8.1 Industry Chain of Gene Therapy
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF GENE THERAPY
9.1 Cost Structure Analysis of Gene Therapy
9.2 Raw Materials Cost Analysis of Gene Therapy
9.3 Labor Cost Analysis of Gene Therapy
9.4 Manufacturing Expenses Analysis of Gene Therapy
CHAPTER 10 MARKETING STATUS ANALYSIS OF GENE THERAPY
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
